FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743009980> ?p ?o ?g. }

• W2743009980 endingPage "68729" @default.
• W2743009980 startingPage "68721" @default.
• W2743009980 abstract "// Jiangeng Yang 1, 2 , Yuchen Liu 1, 2 , Anbang He 1, 2, 3 , Yuhan Liu 1 , Jianting Wu 1 , Xinhui Liao 1 , Zhaojie Lv 1 , Feng Wang 1 and Hongbing Mei 1, 2 1 Department of Urology, Shenzhen Second People’s Hospital, Clinical Institute of Guangzhou Medical University, Shenzhen, China 2 Key Laboratory of Medical Reprogramming Technology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China 3 Anhui Medical University, Anhui, China Correspondence to: Hongbing Mei, email: hbmei68@163.com Keywords: microRNA, urothelial carcinoma, cyclin-dependent kinase inhibitor 2B Received: December 28, 2016     Accepted: July 06, 2017     Published: August 03, 2017 ABSTRACT Background and Objectives: Hsa-miR-429 is increased in bladder cancer. Its roles in bladder cancer are poorly understood. Methods: The expression levels of hsa-miR-429 and cyclin-dependent kinase inhibitor 2B (CDKN2B) were determined using Real-Time qPCR in a total of 50 patients with bladder cancer. Bladder cancer T24 and 5637 cells were transfected CDKN2B siRNA or hsa-miR-429 mimic. CDKN2B expression levels after transfection were detected by Real-Time qPCR and Western blot assay respectively. Binding sites between hsa-miR-429 and 3’-untranslated region of CDKN2B were confirmed by Dual luciferase reporter assay. Cell proliferation was evaluated using MTT and EdU assays. Cell apoptosis was determined using ELISA assay. Results: Higher hsa-miR-429 expression levels were associated with higher tumor grade and stage. All patients with low hsa-miR-429 expression survived 5 years, while with high hsa-miR-429 expression, only 58% survived. Hsa-miR-429 and CDKN2B were inversely expressed in bladder cancer. Hsa-miR-429 mimic decreased the expression of CDKN2B at both mRNA and protein levels. The binding site was confirmed between hsa-miR-429 and 3’-untranslated region of CDKN2B. Up-regulation of hsa-miR-429 or down-regulation of CDKN2B promoted cell growth and decreased apoptosis. Conclusions: Our data suggest a mechanism for hsa-miR-429 to play oncogenic roles via inhibiting CDKN2B." @default.
• W2743009980 created "2017-08-17" @default.
• W2743009980 creator A5020919165 @default.
• W2743009980 creator A5023625917 @default.
• W2743009980 creator A5034202632 @default.
• W2743009980 creator A5036020184 @default.
• W2743009980 creator A5040636328 @default.
• W2743009980 creator A5050773235 @default.
• W2743009980 creator A5068016508 @default.
• W2743009980 creator A5069464278 @default.
• W2743009980 creator A5079129500 @default.
• W2743009980 date "2017-08-03" @default.
• W2743009980 modified "2023-09-27" @default.
• W2743009980 title "Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B" @default.
• W2743009980 cites W182556614 @default.
• W2743009980 cites W1981775300 @default.
• W2743009980 cites W1987531089 @default.
• W2743009980 cites W1989376396 @default.
• W2743009980 cites W2003328564 @default.
• W2743009980 cites W2008014951 @default.
• W2743009980 cites W2008945738 @default.
• W2743009980 cites W2033620247 @default.
• W2743009980 cites W2073073901 @default.
• W2743009980 cites W2076984671 @default.
• W2743009980 cites W2094558682 @default.
• W2743009980 cites W2109984174 @default.
• W2743009980 cites W2133968430 @default.
• W2743009980 cites W2161817637 @default.
• W2743009980 cites W2165349206 @default.
• W2743009980 cites W2189496973 @default.
• W2743009980 cites W2320235820 @default.
• W2743009980 cites W2320485052 @default.
• W2743009980 cites W2414854882 @default.
• W2743009980 cites W2514196188 @default.
• W2743009980 cites W2519661094 @default.
• W2743009980 cites W2523580246 @default.
• W2743009980 cites W2581677211 @default.
• W2743009980 cites W2589047777 @default.
• W2743009980 cites W2590738748 @default.
• W2743009980 doi "https://doi.org/10.18632/oncotarget.19878" @default.
• W2743009980 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5620291" @default.
• W2743009980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28978151" @default.
• W2743009980 hasPublicationYear "2017" @default.
• W2743009980 type Work @default.
• W2743009980 sameAs 2743009980 @default.
• W2743009980 citedByCount "14" @default.
• W2743009980 countsByYear W27430099802018 @default.
• W2743009980 countsByYear W27430099802019 @default.
• W2743009980 countsByYear W27430099802021 @default.
• W2743009980 countsByYear W27430099802022 @default.
• W2743009980 crossrefType "journal-article" @default.
• W2743009980 hasAuthorship W2743009980A5020919165 @default.
• W2743009980 hasAuthorship W2743009980A5023625917 @default.
• W2743009980 hasAuthorship W2743009980A5034202632 @default.
• W2743009980 hasAuthorship W2743009980A5036020184 @default.
• W2743009980 hasAuthorship W2743009980A5040636328 @default.
• W2743009980 hasAuthorship W2743009980A5050773235 @default.
• W2743009980 hasAuthorship W2743009980A5068016508 @default.
• W2743009980 hasAuthorship W2743009980A5069464278 @default.
• W2743009980 hasAuthorship W2743009980A5079129500 @default.
• W2743009980 hasBestOaLocation W27430099801 @default.
• W2743009980 hasConcept C104317684 @default.
• W2743009980 hasConcept C121608353 @default.
• W2743009980 hasConcept C126322002 @default.
• W2743009980 hasConcept C143998085 @default.
• W2743009980 hasConcept C145059251 @default.
• W2743009980 hasConcept C153911025 @default.
• W2743009980 hasConcept C2780352672 @default.
• W2743009980 hasConcept C502942594 @default.
• W2743009980 hasConcept C54009773 @default.
• W2743009980 hasConcept C54355233 @default.
• W2743009980 hasConcept C55493867 @default.
• W2743009980 hasConcept C62112901 @default.
• W2743009980 hasConcept C71924100 @default.
• W2743009980 hasConcept C81885089 @default.
• W2743009980 hasConcept C86803240 @default.
• W2743009980 hasConceptScore W2743009980C104317684 @default.
• W2743009980 hasConceptScore W2743009980C121608353 @default.
• W2743009980 hasConceptScore W2743009980C126322002 @default.
• W2743009980 hasConceptScore W2743009980C143998085 @default.
• W2743009980 hasConceptScore W2743009980C145059251 @default.
• W2743009980 hasConceptScore W2743009980C153911025 @default.
• W2743009980 hasConceptScore W2743009980C2780352672 @default.
• W2743009980 hasConceptScore W2743009980C502942594 @default.
• W2743009980 hasConceptScore W2743009980C54009773 @default.
• W2743009980 hasConceptScore W2743009980C54355233 @default.
• W2743009980 hasConceptScore W2743009980C55493867 @default.
• W2743009980 hasConceptScore W2743009980C62112901 @default.
• W2743009980 hasConceptScore W2743009980C71924100 @default.
• W2743009980 hasConceptScore W2743009980C81885089 @default.
• W2743009980 hasConceptScore W2743009980C86803240 @default.
• W2743009980 hasIssue "40" @default.
• W2743009980 hasLocation W27430099801 @default.
• W2743009980 hasLocation W27430099802 @default.
• W2743009980 hasLocation W27430099803 @default.
• W2743009980 hasLocation W27430099804 @default.
• W2743009980 hasOpenAccess W2743009980 @default.
• W2743009980 hasPrimaryLocation W27430099801 @default.

• next